Preventing heart failure and improving survival

New England Journal of Medicine

Volumn 363, Issue 25, 2010, Pages 2456-2457

  Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CAUSE OF DEATH; CLINICAL ASSESSMENT; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QRS COMPLEX; SURVIVAL;

EID: 78650204495     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1011742     Document Type: Editorial

References (10)

1. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992;327:669-77.
2. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43.
3. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
4. Solomon SD, Foster E, Bourgoun M, et al. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy. Circulation 2010;122:985-92.
5. Tang ASL, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95.
6. Device approvals and clearances. Silver Spring, MD: Food and Drug Administration, September 16, 2010. (http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/DeviceApprovalsandClearances/default.htm.)
7. St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
8. Bertini M, Marsan NA, Delgado V, et al. Effects of cardiac resynchronization therapy on left ventricular twist. J Am Coll Cardiol 2009;54:1317-25.
9. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-9. [Erratum, Circulation 2001;103:476.]
10. Jessup M. MADIT-CRT - breathtaking or time to catch our breath? N Engl J Med 2009;361:1394-6.